Cold & Cough Remedies - EAEU

  • EAEU
  • In 2024, the revenue generated in the Cold & Cough Remedies market market in the country in Eurasian Economic Union (EAEU) amounts to US$1.33bn.
  • It is projected that the market will experience an annual growth rate of 4.15% (CAGR 2024-2029).
  • When comparing this market globally, the in the United States leads in revenue generation with US$11,190.00m in 2024.
  • In terms of per capita revenue, each person in the country in Eurasian Economic Union (EAEU) contributes US$7.29 in 2024.
  • The EAEU market for cold & cough remedies is experiencing a surge in demand due to the region's harsh winters and high prevalence of respiratory illnesses.

Key regions: United States, Japan, Australia, United Kingdom, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in EAEU is experiencing significant growth due to several factors. Customer preferences for over-the-counter remedies, increasing awareness about the importance of self-care, and the rising incidence of cold and cough are driving the market expansion. Additionally, local special circumstances and underlying macroeconomic factors are contributing to the development of the market in the EAEU region.Customer preferences in the EAEU region are shifting towards over-the-counter remedies for cold and cough. This is mainly due to the convenience and accessibility of these products. Consumers prefer to treat their symptoms at home without the need for a doctor's prescription. Over-the-counter remedies provide them with a quick and easy solution to alleviate their discomfort. This preference for self-care is driving the demand for cold and cough remedies in the EAEU market.The market is also benefiting from increasing awareness about the importance of self-care. Consumers are becoming more proactive in managing their health and are willing to take preventive measures to avoid falling sick. This includes using cold and cough remedies to alleviate symptoms and prevent the spread of infections. The growing emphasis on self-care is fueling the demand for these products in the EAEU region.The rising incidence of cold and cough is another key driver of market growth. The EAEU region experiences harsh winters, which increases the likelihood of individuals falling sick. The cold weather and low temperatures make people more susceptible to respiratory infections. As a result, there is a higher demand for cold and cough remedies during the winter months. The prevalence of cold and cough in the region is contributing to the expansion of the market.Local special circumstances in the EAEU region also play a role in the development of the Cold & Cough Remedies market. The region consists of several countries with diverse healthcare systems and regulations. This can impact the availability and accessibility of cold and cough remedies. Some countries may have stricter regulations on the sale and distribution of these products, while others may have a more relaxed approach. These local circumstances influence the market dynamics and consumer behavior in the region.Underlying macroeconomic factors are also contributing to the growth of the Cold & Cough Remedies market in the EAEU region. Economic stability and increasing disposable incomes enable consumers to afford these products. As the economies in the EAEU region continue to grow, more individuals have the purchasing power to buy cold and cough remedies. Additionally, advancements in healthcare infrastructure and the availability of a wide range of products further support market expansion.In conclusion, the Cold & Cough Remedies market in the EAEU region is witnessing growth due to customer preferences for over-the-counter remedies, increasing awareness about self-care, and the rising incidence of cold and cough. Local special circumstances and underlying macroeconomic factors also contribute to the development of the market. As the region continues to experience these trends and factors, the market is expected to further expand in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)